Group items tagged

Segmentation of the global dental and oral hygiene product market by product type assists in understanding key areas of growth. An in-depth analysis of the historic development, current market situation, trends offer a perspective on the future prospects of the dental and oral hygiene product market in the world as well as in different countries to 2017. Key products include dentifrices, dental floss, other dental and oral hygiene products.

The launch of Protease Inhibitors (PIs) accelerated the pace of innovation and impressive Sustained Virologic Response (SVR) rates by oral IFN free drug combinations. Freedom from IFN, treating all genotypes and vaccines could bring a sea of change in the HCV therapy class area in the future. Roche set the trend with the acquisition of Anadys for total of USD 230 mn followed by GILD buying VRUS for USD 11 bn, Bristol-Myers Squibb (BMY) acquiring Inhibitex for USD 2.5 bn, VRTX acquiring Virochem in 2009 for USD 375 mn, In-licensed Alios VX-135 in 2012 for total of USD 775 mn and Abbott in-licensed Enantas ABT-450 for total of USD 310 mn.

An extensive analysis of the cosmetic and toiletry product markets in the world displays a strong growth pattern. Segmentation of cosmetic and toiletry product by type segregates the fast growing products and displays a prospective future. Key product segments include soap, dental and oral hygiene products, hair products, make-up, skin care and beauty products, toilet waters and perfumes, shaving products, antiperspirants and deodorants, bath products, room deodorizing and perfuming products.